Lakeshore Biopharma (LSB) Expected to Announce Quarterly Earnings on Monday

Lakeshore Biopharma (NASDAQ:LSBGet Free Report) is expected to issue its quarterly earnings data before the market opens on Monday, January 27th. Analysts expect Lakeshore Biopharma to post earnings of ($0.80) per share for the quarter.

Lakeshore Biopharma Trading Up 12.9 %

NASDAQ:LSB opened at $2.63 on Friday. The company has a fifty day moving average of $2.86. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.90 and a current ratio of 1.17. Lakeshore Biopharma has a one year low of $1.88 and a one year high of $11.20.

About Lakeshore Biopharma

(Get Free Report)

LakeShore Biopharma Co, Ltd. engages in the provision of discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People’s Republic of China and Other Countries or Regions.

See Also

Earnings History for Lakeshore Biopharma (NASDAQ:LSB)

Receive News & Ratings for Lakeshore Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeshore Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.